by Brianna Crandall — August 5, 2015—Global professional services and investment management firm JLL (Jones Lang LaSalle) just announced that Bristol-Myers Squibb (BMS), a global biopharmaceutical company, selected the firm to be a provider of facilities management and occupancy planning services for its 10 million-square-foot portfolio in the United States and Puerto Rico.
The agreement encompasses 16 manufacturing, laboratory, research and development (R&D) and office sites. JLL is responsible for delivering industry-leading facilities management services and effective cost management and reporting.
To help life sciences companies maintain a laser focus on operating efficiency and productivity, JLL says it offers a unique FM platform and has a strong track record in engineering and operations in regulated environments, as well as a value-based, holistic service delivery platform.
JLL’s full-service life sciences platform includes integrated FM, engineering and operations, energy and sustainability, transaction advisory, lease administration, project management, and the Labwell platform for comprehensive laboratory services.
JLL currently manages more than 100 million square feet of life sciences facilities, including offices, BL-2 and BL-3+ laboratories, clean rooms, vivariums, biorepositories, manufacturing and other technical facilities.
